Theresa M. Salay
Johns Hopkins University · 8 works · 11,520 citations · h-index 7
Top works
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- Structural Basis for the Presentation of Tumor-Associated MHC Class II-Restricted Phosphopeptides to CD4+ T Cells
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-γ
- Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy
- Role of β-Catenin in B Cell Development and Function
- Crystal structure of a gp100:44-59 peptide-HLA-DR4 complex enables design of an altered peptide ligand with enhanced immunogenicity (100.25)